PAVmed (PAVM) Gains from Investment Securities (2017 - 2019)
PAVmed's (PAVM) quarterly Gains from Investment Securities came in at $3.4 million in Q1 2019, up 3459.76% year-on-year from $96480.0 in Q1 2018, and up 3459.76% quarter-over-quarter from $96480.0 in Q1 2018.
PAVmed (PAVM) Gains from Investment Securities (2017 - 2019) Analysis & Trends
PAVmed's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $3.4 million for Q1 2019.
- On a quarterly basis, Gains from Investment Securities rose 3459.76% year-over-year to $3.4 million in Q1 2019; TTM through Mar 2019 was $3.4 million, a 424.12% increase from a year earlier, with the FY2018 full-year figure at $96480.0, up 104.97% from the prior year.
- Gains from Investment Securities grew to $3.4 million in Q1 2019 per PAVM's latest filing, from $96480.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $3.4 million in Q1 2019 and bottomed at -$2.6 million in Q4 2017.
- The 3-year median for Gains from Investment Securities is -$325971.5 (2017), against an average of $264738.5.
- Across the five-year window, Gains from Investment Securities soared 112.27% in 2018 and jumped 3459.76% in 2019, its largest moves.
- Year by year, Gains from Investment Securities stood at -$2.6 million in 2017, then surged by 103.68% to $96480.0 in 2018, then soared by 3459.76% to $3.4 million in 2019.
- Per Business Quant, the three latest PAVM Gains from Investment Securities figures stand at $3.4 million (Q1 2019), $96480.0 (Q1 2018), and -$2.6 million (Q4 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | PAVmed | 11.39 Mn | 9.86 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 3.43 Mn |
| Mar 31, 2019 | 3.43 Mn |
| Mar 31, 2018 | 96,480.00 |
| Mar 31, 2018 | 96,480.00 |
| Dec 31, 2017 | -2.62 Mn |
| Dec 31, 2017 | -2.62 Mn |
| Sep 30, 2017 | 2.22 Mn |
| Sep 30, 2017 | 2.22 Mn |
| Jun 30, 2017 | -748,423.00 |
| Jun 30, 2017 | -748,423.00 |
| Mar 31, 2017 | -786,397.00 |
| Mar 31, 2017 | -786,397.00 |